INSIGHT-IBD Pragmatic Study
ENROLLING_BY_INVITATION
Status
Conditions
- Ulcerative Colitis (UC)
- Crohn Disease (CD)
Interventions
- DRUG: Mirikizumab
- DRUG: Anti-TNF agents
- DRUG: anti-integrin antibodies
- DRUG: IL-12
- DRUG: IL-23
Sponsor
Specialty Networks Research.
Collaborators